InnovAge (INNV) director receives 8,539 RSUs vesting in 2027
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
FONTNEAU PATRICIA reported acquisition or exercise transactions in this Form 4 filing.
InnovAge Holding Corp. director Patricia Fontneau received a grant of 8,539 Restricted Stock Units, or RSUs, that will settle in shares of common stock. The award was recorded at a price of $0.00 per share, reflecting compensation rather than an open-market purchase. After this grant, Fontneau holds 70,664 shares directly. The RSUs vest in full on June 30, 2027, provided she continues her service with the company.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
FONTNEAU PATRICIA
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, $0.001 par value | 8,539 | $0.00 | -- |
Holdings After Transaction:
Common Stock, $0.001 par value — 70,664 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
RSUs granted: 8,539 units
Holding after transaction: 70,664 shares
Grant price: $0.00 per share
+1 more
4 metrics
RSUs granted
8,539 units
Restricted Stock Units awarded to director on July 1, 2026
Holding after transaction
70,664 shares
Total InnovAge common shares held directly after grant
Grant price
$0.00 per share
Compensation-related RSU award, not open-market purchase
Vesting date
June 30, 2027
RSUs vest in full if service with issuer continues
Key Terms
Restricted Stock Units ("RSUs"), vest in full, Grant, award, or other acquisition
3 terms
Restricted Stock Units ("RSUs") financial
"Represents Restricted Stock Units ("RSUs") which will be settled in shares of common stock"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
vest in full financial
"and will vest in full on June 30, 2027, subject to the Reporting Person's continued service"
Grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
FAQ
What did InnovAge (INNV) director Patricia Fontneau report in this Form 4?
Patricia Fontneau reported receiving 8,539 Restricted Stock Units as compensation. These RSUs will convert into InnovAge common shares upon vesting, increasing her equity stake if she remains with the company through the full vesting date.
When do Patricia Fontneau’s InnovAge (INNV) RSUs from this filing vest?
The 8,539 Restricted Stock Units vest in full on June 30, 2027. Vesting is contingent on Patricia Fontneau’s continued service with InnovAge, meaning she must remain in her role through that date for the RSUs to convert into common shares.
Was Patricia Fontneau’s InnovAge (INNV) RSU grant an open-market stock purchase?
No, the RSU grant was not an open-market purchase. The Form 4 lists the transaction code as a grant or award at a price of $0.00 per share, indicating compensation rather than stock bought on the public market by the director.
What type of security did InnovAge (INNV) grant to Patricia Fontneau in this transaction?
InnovAge granted Patricia Fontneau Restricted Stock Units that will be settled in common stock. These RSUs represent a right to receive InnovAge shares in the future, subject to vesting conditions tied to her continued service with the company through June 30, 2027.